Multiplex RPA-CRISPR/Cas12a Assay for Rapid Detection of Class D OXA-Type Carbapenem-Resistant Acinetobacter baumannii
Biosensors · 05.08.2026 · 16 (8) · 422
DOI: 10.3390/bios16080422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 05.08.2026. Verfasst von Meruyert Amanzholova und 6 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Biotechnology, Astana 010000, Kazakhstan. Hauptthemen laut MEDLINE: Acinetobacter baumannii, beta-Lactamases. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan.
Abstract (Originalsprache)
Acinetobacter baumannii is a critical WHO priority pathogen due to its multidrug resistance and high mortality in carbapenem-resistant infections. Resistance is predominantly mediated by class D carbapenemase genes blaOXA-23 and blaOXA-40, which spread rapidly via horizontal gene transfer in healthcare settings. To address the lack of a rapid assay capable of detecting both blaOXA-23 and blaOXA-40 in a single analytical workflow, we developed a multiplex two-step RPA–CRISPR/Cas12a assay. Since infections caused by strains harboring either gene require identical therapeutic management, their co-detection in a single reaction is clinically justified. Although simultaneous use of two crRNAs within a single CRISPR/Cas12a reaction is often considered technically challenging due to potential inter-crRNA competition, here it advantageously enables dual-target coverage without compromising sensitivity. The assay demonstrated high specificity with no cross-reactivity against a panel of clinically relevant bacterial species, including closely related Acinetobacter spp. Evaluation using genomic DNA extracted from 63 cultured clinical A. baumannii isolates revealed blaOXA-23 in 19 isolates (30.2%), blaOXA-40 in 28 (44.4%), and co-carriage of both genes in 9 (14.3%), with at least one resistance gene detected in 60.3% of isolates. The complete workflow was accomplished within 45 min without specialized equipment, offering a rapid, sensitive, and cost-effective solution for point-of-care molecular surveillance of carbapenem-resistant A. baumannii in clinical and resource-limited settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Center for Biotechnology, Astana 010000, Kazakhstan.
- Faculty of Biology and Biotechnology, Farabi Kazakh National University, Almaty 010000, Kazakhstan.
- Department of Microbiology and Virology, Astana Medical University, Astana 010000, Kazakhstan.
- National Scientific Medical Center, Astana 010000, Kazakhstan.
ORCID-Profile: Meruyert Amanzholova, Nazgul Sutimbekova, Pavel Tarlykov, Sailau Abeldenov
Förderung
- Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan
Zitieren
APA
Amanzholova, M., Akimbekova, A., Shaizadinova, A., Sutimbekova, N., Bissenova, N., Tarlykov, P., & Abeldenov, S. (2026). Multiplex RPA-CRISPR/Cas12a Assay for Rapid Detection of Class D OXA-Type Carbapenem-Resistant Acinetobacter baumannii. Biosensors, 16(8), 422. https://doi.org/10.3390/bios16080422
Vancouver
Amanzholova M, Akimbekova A, Shaizadinova A, Sutimbekova N, Bissenova N, Tarlykov P, et al. Multiplex RPA-CRISPR/Cas12a Assay for Rapid Detection of Class D OXA-Type Carbapenem-Resistant Acinetobacter baumannii. Biosensors. 2026;16(8):422. doi:10.3390/bios16080422
BibTeX
@article{Amanzholova2026,
author = {Amanzholova, Meruyert and Akimbekova, Ainur and Shaizadinova, Aisha and Sutimbekova, Nazgul and Bissenova, Nelya and Tarlykov, Pavel and Abeldenov, Sailau},
title = {Multiplex RPA-CRISPR/Cas12a Assay for Rapid Detection of Class D OXA-Type Carbapenem-Resistant Acinetobacter baumannii},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {8},
pages = {422},
doi = {10.3390/bios16080422}
}
EUVIMED